Sanaria Inc.
Rockville, MD
- UEI
- YLF2SS2NYGC5
- CAGE
- 30DP1
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
-
- 541714 Research and Development in Biotechnology (except Nanobiotechnology) Primary
- 325412 Pharmaceutical Preparation Manufacturing
- 325414 Biological Product (except Diagnostic) Manufacturing
- 541690 Other Scientific and Technical Consulting Services
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration date
- Physical address
- 9610 Medical Center Dr #200, Rockville, MD 20850, USA
- Website
- sanaria.com
- Founded
- 2003
- Employees
- 51-250
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Pfspz reagents biological kits (ambis #2228227) | National Institute of Allergy and Infectious Diseases | $64,000 | |
| Modularizing manufacture of pfspz vaccines: ookinete production for pfspz manufacture in mosquitoes and in vitro - in… | National Institute of Allergy and Infectious Diseases | $558,840 | |
| Asexual malaria blood culture service for ncats | National Institute on Drug Abuse | $89,055 | |
| Progressing pfspz vaccines for malaria to licensure and commercialization - abstract sanaria's mission is the… | National Institute of Allergy and Infectious Diseases | $4,989,331 | |
| Conditional male lethal anopheles stephensi line for the efficient manufacture of malaria vaccines - project abstract in… | National Institute of Allergy and Infectious Diseases | $1,499,902 |
About Sanaria Inc.
Sanaria Inc. is a biotechnology company based in Rockville, Maryland, specializing in the development of malaria vaccines and related biological research. The company focuses on creating innovative solutions for malaria prevention, particularly through the development of Plasmodium falciparum sporozoite (PfSPZ) vaccines. As a for-profit, veteran-owned business registered in SAM.gov, Sanaria Inc. provides specialized biological research services, vaccine development, and scientific research products to federal agencies, with a primary emphasis on malaria-related scientific advancements.
Through federal contract awards, Sanaria Inc. has primarily worked with agencies like the National Institute of Allergy and Infectious Diseases (NIAID) and the National Center for Advancing Translational Sciences (NCATS). The company has secured several purchase order contracts for specialized biological services, including the provision of PfSPZ reagent biological kits, asexual malaria blood culture services, and research-oriented biological materials. These contracts have ranged in value from $43,467 to $89,054, typically involving the delivery of specific biological products and services supporting medical research. The contracts were awarded on a non-set-aside basis, demonstrating the company's unique capabilities in providing specialized malaria-related biological research materials.
Sanaria Inc. has been awarded multiple federal grants, predominantly from the National Institute of Allergy and Infectious Diseases, focusing on advanced malaria vaccine research and development. The grant awards support various critical research initiatives, including modularizing PfSPZ vaccine manufacture, developing conditional male lethal Anopheles stephensi lines, and creating genetically modified sporozoite vaccines. These grants range from Small Business Innovation Research (SBIR) program phases to cooperative agreements, with award values between $43,000 and $298,596. The research aims to improve malaria vaccine efficacy, develop more efficient manufacturing processes, and explore innovative approaches to malaria prevention. The company has also engaged in sub-grant collaborations with institutions like the University of Maryland, Baltimore, and Seattle Children's Hospital, expanding its research network and scientific impact.
Quick answers
What is Sanaria Inc.'s UEI?
Sanaria Inc.'s Unique Entity ID (UEI) in SAM.gov is YLF2SS2NYGC5.
What is Sanaria Inc.'s CAGE code?
Sanaria Inc.'s CAGE code is 30DP1.
What is Sanaria Inc.'s primary NAICS code?
Sanaria Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Sanaria Inc. located?
Sanaria Inc.'s physical address in SAM.gov is 9610 Medical Center Dr #200, Rockville, MD 20850, USA.
Is Sanaria Inc. registered in SAM.gov?
Yes. Sanaria Inc.'s SAM.gov registration is active through September 10, 2027.
What is Sanaria Inc.'s most recent federal award?
Sanaria Inc.'s most recent federal contract award is Pfspz reagents biological kits (ambis #2228227) (75N93024P00793), from National Institute of Allergy and Infectious Diseases, on June 28, 2024.
On GovTribe
See Sanaria Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors